VTYX
VTYX
NASDAQ · Pharmaceuticals

Ventyx Biosciences Inc

$14.00
+0.02 (+0.14%)
As of Apr 25, 1:37 AM ET ·
Analyst Consensus
Hold
15
Analysts
High
Coverage
Buy 6 40%
Hold 9 60%
Sell 0 0%
Price Target
Analyst Price Target +351.1% upside
Low Target $39.88
Average Target $63.16
High Target $74.20
Current Price $14.00
Current
$14.00
Target
$63.16
$39.88 $63.16 avg $74.20
Scenario Analysis
Bear Case
$39.88
184.9%
Low target
Base Case
$63.16
+351.1%
Avg target
Bull Case
$74.20
+430.0%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$25.00
-44.0% from high
52-Week Low
$1.05
+1,233.3% from low
Target vs 52W High
$63.16
+152.6% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%